MV

Michael Volk

Co-Founder & Chief Science Officer (CSO)

Reven Pharmaceuticals

Reven Pharmaceuticals Pipeline

DrugIndicationPhase
RJXCOVID-19 ARDS and SepsisPhase 1/2
RJX PlatformVascular, Oncology, CNS, Ocular DiseasesResearch/Preclinical